Literature DB >> 16959267

Apolipoprotein E gene polymorphism and previous alcohol withdrawal seizures.

Julia Wilhelm1, Nicolas von Ahsen, Thomas Hillemacher, Kristina Bayerlein, Helge Frieling, Johannes Kornhuber, Stefan Bleich.   

Abstract

Aim of this study was to investigate the possible association of apolipoprotein E (ApoE) gene polymorphism with a history of alcohol withdrawal seizures. We included 194 patients with alcohol dependence who were divided into patients with (SZ+) and without (SZ-) previous alcohol withdrawal seizures. ApoE genotypes were determined using PCR. For statistical analysis we examined the number of ApoE alleles (ApoE2: n=36; ApoE3: n=311; ApoE4: n=41). A significant positive association with a positive history of withdrawal seizures (SZ+) was found in the ApoE3 allele group (Fisher's exact test: p=0.006) while a significant negative association was observed in the ApoE2 allele group (Fisher's exact test: p=0.029). For the ApoE4 allele group no significant differences were found regarding a history of withdrawal seizures. Our findings suggest an association between the apolipoprotein E3 gene variant and an elevated risk of alcohol withdrawal seizures. These preliminary results must be validated in further studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959267     DOI: 10.1016/j.jpsychires.2006.07.011

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  2 in total

1.  Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice.

Authors:  Jessica A Siegel; Michael J Craytor; Jacob Raber
Journal:  Behav Pharmacol       Date:  2010-10       Impact factor: 2.293

2.  Lipid profile dysregulation predicts alcohol withdrawal symptom severity in individuals with alcohol use disorder.

Authors:  Daniel B Rosoff; Katrin Charlet; Jeesun Jung; Jisoo Lee; Christine Muench; Audrey Luo; Martha Longley; Falk W Lohoff
Journal:  Alcohol       Date:  2020-04-23       Impact factor: 2.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.